NEI Research News

An international team led by Harvard Medical School scientists has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, a devastating condition that runs in families.

A pilot study of 106 patients with “wet” AMD revealed that nearly half of patients treated with Eylea could safely stop therapy after one year, compared to only 17% of patients treated with Avastin.

A new study from Duke University finds that single neurons conveying visual information about two separate objects in sight do so by alternating signals about one or the other.

Researchers from the University of Illinois shed light on how neural stem cells called neuroblasts divide multiple times to sequentially produce neurons of specialized function.

Jordan Hamm, an assistant professor of neuroscience at Georgia State University, has received a five-year, $1.93 million award from the National Eye Institute.

Researchers say findings reveal potential glaucoma drugs targets.

Rogue clinics offer stem cell-based therapies that haven’t been tested for safety and efficacy. When communicating to the public about stem cell-based therapies, it is important to put any treatment claims in context.

A UCLA-led group found that the eye drug verteporfin stops replication of SARS-CoV-2, the virus that causes COVID-19.

Columbia University researchers examined what goes wrong in the eyes of mice with albinism.

NEI grant will support examining impact of pain and inflammation on eye’s surface and possible link to diseases.